Ixodes scapularis is a primary vector of tick-borne pathogens in North America. Repeated exposure to these ticks can induce a humoral response to tick antigens and acquired tick resistance. However, identifying antigens contributing to this resistance is challenging because of the vast number of I. scapularis proteins secreted during feeding. To address this, we developed I. scapularis rapid extracellular antigen monitoring (IscREAM), a technique to detect antibody responses to more than 3000 tick antigens. We validated IscREAM with immunoglobulin G (IgG) from guinea pigs vaccinated with tick antigens, including a cement antigen cocktail that induced tick resistance. Furthermore, we explored the natural response to tick bites by profiling antigens recognized by IgG isolated from a tick-resistant individual, as well as from others with Lyme disease and tick-bitten guinea pigs and mice, to identify 199 recognized antigens. We observed that several antigens contained histamine-binding domains. This work enhances our understanding of the host immune response to I. scapularis and defines immunogen candidates for future antitick vaccines.
Tick feeding or vaccination with tick antigens elicits immunity to the Ixodes scapularis exoproteome in guinea pigs and humans.
蜱虫叮咬或用蜱虫抗原进行疫苗接种可使豚鼠和人类对肩胛硬蜱外蛋白组产生免疫力
阅读:10
作者:Hart Thomas M, Cui Yingjun, Telford Sam R, MarÃn-López Alejandro, Calloway Keith, Dai Yile, Matias Jaqueline, DePonte Kathleen, Jaycox Jillian, DeBlasio Melody, Hoornstra Dieuwertje, Belperron Alexia A, Cibichakravarthy Balasubramanian, Johnson Emily E, Alameh Mohamad-Gabriel, Dwivedi Garima, Hovius Joppe W R, Bockenstedt Linda K, Weissman Drew, Ring Aaron M, Fikrig Erol
| 期刊: | Science Translational Medicine | 影响因子: | 14.600 |
| 时间: | 2025 | 起止号: | 2025 Mar 26; 17(791):eads9207 |
| doi: | 10.1126/scitranslmed.ads9207 | 种属: | Human |
| 研究方向: | 其它 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
